| α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease I Lastres-Becker, A Ulusoy, NG Innamorato, G Sahin, A Rábano, D Kirik, ... Human molecular genetics 21 (14), 3173-3192, 2012 | 278 | 2012 |
| Dose optimization for long-term rAAV-mediated RNA interference in the nigrostriatal projection neurons A Ulusoy, G Sahin, T Björklund, P Aebischer, D Kirik Molecular Therapy 17 (9), 1574-1584, 2009 | 93 | 2009 |
| Functional convergence of dopaminergic and cholinergic input is critical for hippocampus-dependent working memory LAB Wisman, G Sahin, M Maingay, G Leanza, D Kirik Journal of Neuroscience 28 (31), 7797-7807, 2008 | 76 | 2008 |
| Primary angiitis of the central nervous system and silent cortical hemorrhages H Ay, G Şahin, I Saatci, F Söylemezoğlu, O Sarıbaş American journal of neuroradiology 23 (9), 1561-1563, 2002 | 73 | 2002 |
| Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA–induced dyskinesia in rats A Ulusoy, G Sahin, D Kirik Proceedings of the National Academy of Sciences 107 (29), 13159-13164, 2010 | 65 | 2010 |
| Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease F Febbraro, G Sahin, A Farran, S Soares, PH Jensen, D Kirik, ... Neurobiology of disease 56, 47-58, 2013 | 53 | 2013 |
| Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease E Cederfjäll, G Sahin, D Kirik, T Björklund Molecular Therapy 20 (7), 1315-1326, 2012 | 45 | 2012 |
| Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease E Cederfjäll, N Nilsson, G Sahin, Y Chu, E Nikitidou, T Björklund, ... Scientific reports 3 (1), 2157, 2013 | 35 | 2013 |
| Posterior leukoencephalopathy and nephrotic syndrome: just a coincidence? DY Aksoy, M Arici, AA Kiykim, M Durusu, B Altun, Y Erdem, U Yasavul, ... The American journal of the medical sciences 327 (3), 156-159, 2004 | 28 | 2004 |
| Acute bilateral cerebellar infarction in the territory of the medial branches of posterior inferior cerebellar arteries G Gurer, G Sahin, S Cekirge, E Tan, O Saribas Clinical neurology and neurosurgery 103 (3), 194-196, 2001 | 19 | 2001 |
| Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease G Sahin, LH Thompson, S Lavisse, M Ozgur, L Rbah-Vidal, F Dollé, ... PLoS One 9 (3), e90759, 2014 | 18 | 2014 |
| Effect of polymorphism on in vitro-in vivo properties of carbamazepine conventional tablets R Elqidra, N Ünlü, Y Çapan, G Sahin, T Dalkara, AA Hincal Journal of Drug Delivery Science and Technology 14 (2), 147-153, 2004 | 18 | 2004 |
| Familial parkinsonism with apathy, depression and central hypoventilation (Perry’s syndrome) B Elibol, T Kobayashi, FB Ataç, N Hattori, G Şahin, G Gürer, Y Mizuno Mapping the Progress of Alzheimer’s and Parkinson’s Disease, 285-290, 2002 | 18 | 2002 |
| Neuroinflammation in parkinson’s disease and its treatment opportunities E Çınar, BC Tel, G Şahin Balkan medical journal 39 (5), 318, 2022 | 14 | 2022 |
| Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain E Cederfjäll, G Sahin, D Kirik Neurobiology of disease 48 (2), 222-227, 2012 | 12 | 2012 |
| Management of vertebral stenosis complicated by presence of acute thrombus M Canyigit, A Arat, BE Cil, G Sahin, B Turkbey, B Elibol Cardiovascular and interventional radiology 30, 317-320, 2007 | 10 | 2007 |
| Focal EEG findings in juvenile absence syndrome and the effect of antiepileptic drugs FI Tezer, G Sahin, A Ciger, S Saygi Clinical EEG and neuroscience 39 (1), 33-38, 2008 | 9 | 2008 |
| Tremor evaluation using smartphone accelerometry in standardized settings G Sahin, P Halje, S Uzun, A Jakobsson, P Petersson Frontiers in Neuroscience 16, 861668, 2022 | 5 | 2022 |
| 26 Efficacy of L-DOPA Therapy in Parkinson’s Disease G Sahin, D Kirik and Health, 454, 2012 | 5 | 2012 |
| Effectiveness of fremanezumab for preventive treatment of migraine: The observational PEARL study M Ashina, D Mitsikostas, F Amin, P Kokturk, A Poole, G Sahin, C Schankin, ... EUROPEAN JOURNAL OF NEUROLOGY 29, 192-193, 2022 | 3 | 2022 |
Deniz KirikProfessor of NeuroscienceVerified email at med.lu.se
